...
首页> 外文期刊>Allergy >Influenza burden, prevention, and treatment in asthma‐A scoping review by the EAACI EAACI Influenza in asthma task force
【24h】

Influenza burden, prevention, and treatment in asthma‐A scoping review by the EAACI EAACI Influenza in asthma task force

机译:哮喘的流感负担,预防和治疗 - 哮喘工作队中EAACI eAaci流感的审查

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract To address uncertainties in the prevention and management of influenza in people with asthma, we performed a scoping review of the published literature on influenza burden; current vaccine recommendations; vaccination coverage; immunogenicity, efficacy, effectiveness, and safety of influenza vaccines; and the benefits of antiviral drugs in people with asthma. We found significant variation in the reported rates of influenza detection in individuals with acute asthma exacerbations making it unclear to what degree influenza causes exacerbations of underlying asthma. The strongest evidence of an association was seen in studies of children. Countries in the European Union currently recommend influenza vaccination of adults with asthma; however, coverage varied between regions. Coverage was lower among children with asthma. Limited data suggest that good seroprotection and seroconversion can be achieved in both children and adults with asthma and that vaccination confers a degree of protection against influenza illness and asthma‐related morbidity to children with asthma. There were insufficient data to determine efficacy in adults. Overall, influenza vaccines appeared to be safe for people with asthma. We identify knowledge gaps and make recommendations on future research needs in relation to influenza in patients with asthma.
机译:None

著录项

  • 来源
    《Allergy》 |2018年第6期|共31页
  • 作者单位

    Centre for Inflammation ResearchUniversity of EdinburghEdinburgh UK;

    Respiratory SciencesImperial College LondonLondon UK;

    Respiratory SciencesImperial College LondonLondon UK;

    Department of Medical Sciences and Public Health “M. Aresu”University of CagliariCagliari Italy;

    Department of Medical Sciences and Public Health “M. Aresu”University of CagliariCagliari Italy;

    Department of Pediatric AllergologyKing's CollegeLondon UK;

    Faculty of MedicineUniversity of SouthamptonNewport Isle of Wight UK;

    Faculty of MedicineUniversity of SouthamptonNewport Isle of Wight UK;

    Swiss Institute of Allergy and Asthma ResearchUniversity of ZurichDavos Switzerland;

    Department of Allergy and Clinical ImmunologyTransylvania University BrasovBrasov Romania;

    Department of PaediatricsImperial College LondonLondon UK;

    Personalized MedicineHumanitas UniversityMilan Italy;

    Department of Medical MicrobiologyNational Kapodistrian University of AthensAthens Greece;

    National Research Center Institute of Immunology of Federal Medicobiological AgencyMoscow Russia;

    National Research Center Institute of Immunology of Federal Medicobiological AgencyMoscow Russia;

    Division of Infection Inflammation &

    Respiratory MedicineThe University of ManchesterManchester UK;

    Department of Health and Hospital ManagementKorangi CreekKarachi 75190 Pakistan;

    Division of Population MedicineCardiff UniversityWales UK;

    Institute of Laboratory Medicine and PathobiochemistryPhilipps University MarburgMarburg Germany;

    Asthma UK Centre for Applied ResearchThe University of EdinburghEdinburgh UK;

    Institute of Laboratory Medicine and PathobiochemistryPhilipps University MarburgMarburg Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

    antivirals; heath care utilization; respiratory; vaccination; viral infection;

    机译:抗病毒药人;医疗保健利用;呼吸道;疫苗接种;病毒感染;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号